We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shire | LSE:SHP | London | Ordinary Share | JE00B2QKY057 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4,690.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
25/6/2014 12:54 | montyhedge- would have been killed following your advice ! I am sorry I was out today when the big spike occurred but a great trading stock every day for anyonwe who wants to make fast money ! ( smile ) | arja | |
24/6/2014 13:11 | motoring now lead by SHP futures in USA ! | arja | |
24/6/2014 10:48 | hope they are right and US punters were in a more optimistic mood about SHP than they are in UK ! Might pick up here from 11.30am | arja | |
24/6/2014 09:52 | MontyI see piper jaff have upped there shire tgt to $280 or approx £54.90 UK line | pinkalltheway | |
24/6/2014 07:19 | P.e 60 best short in the market, unless the bid happens and it won't. | montyhedge | |
24/6/2014 07:17 | Hedgies will soon start shorting Shire, the same way they shorted Astra Zen, these deals never happen. | montyhedge | |
24/6/2014 07:04 | such a quiet board for such a dynamic stock . should open higher today ! | arja | |
23/6/2014 13:24 | recovered well from a bad start but now US futures leading and hence the retreat . | arja | |
22/6/2014 11:10 | Panmure Gordon analyst Savvas Neophytou said Shire could be worth as much as £55 a share and noted the "distinct lack of the word 'final'" anywhere in AbbVie's announcement despite talks no longer taking place. | zho | |
22/6/2014 09:15 | Shire will ramp up its defence against US pharmaceutical bidder AbbVie on Monday as it seeks to convince shareholders of the long-term prospects of the company. | zho | |
20/6/2014 20:23 | the_doctor - amazing how often I get lucky in this type of situation ( t/o situations) ! you make your own luck in this trading business and I often buy stocks when at all time high as NOR situation - buy high to go higher with chart telling the story . it is all about making money and not saying a stock is over valued as the market says what it is worth at any given moment . I have even traded it in USA this evening to make a bit more as so volatile of course ! | arja | |
20/6/2014 16:20 | Took my profit just now. Probably a mistake but nearly 20% in 3-4 days is not bad going in my book. Sven | sven2006 | |
20/6/2014 15:24 | re possibility of Pfizer going for Shire when AZ rejected Unlike Pfizer, AbbVie is suitable for SHP :o) the_doctor 19 May'14 - 13:27 - 794 of 825 0 0 edit I dont think so. The target needs to be of a certain size etc for Pfizer to get the tax benefits it wanted (so I've been told). Shire wouldnt fit that bill It could tick that box for another company maybe, but apparently not Pfizer | the_doctor | |
20/6/2014 14:10 | "AbbVie Inc. (ABBV:US) is considering raising its takeover offer for drugmaker Shire Plc (SHP) a fourth time, and presenting its case to Shire's shareholders after the company rejected a $46.5 billion bid recently, said two people with knowledge of the matter." | protean | |
20/6/2014 13:29 | The news has sent its shares soaring 447p or 12% to £41.85, making it the biggest riser in the FTSE 100. Savvas Neophytou at Panmure Gordon said: Shire's rare diseases business is one of the hottest assets in biopharmaceuticals. It has not been a surprise seeing Abbvie's approach which was rejected. The offer of £46.26 implying some 25 time PE for a 25% growth stock is barely adequate and, depending on circumstances regarding the possible benefits of tax inversion, Abbvie may be able to increase its offer to more than £50, which we believe will be required to make this deal happen. We increase our price target to £46.26 (from £38.00 previously) and re-iterate our buy recommendation. | zho | |
20/6/2014 13:02 | the_doctor, I agree after all thats why people are invested - to make money ! From here though I think we will consolidate at these levels like AZN, both BOD's stated that they are both totally undervalued. I expect larger bids for both in the coming months. Sven | sven2006 | |
20/6/2014 12:36 | 11.5% gain vs. 13.7% then Given you were buying at what was nearly 100% higher than a year ago and the stock could easily have slipped back for one reason or another as it did in Q1, I'd look on the bright side. For a few days of holding, you got very lucky. Acta - a massive premium would not be value destruction for shareholders AZN is not a 'high growth company'. In fact, until the PFE bid, people could only talk about its problems. If they dont renew the PFE interest, I doubt the share price will ever see these levels again Similarly, SHP at these levels is overstretched. A PE of 60x does not reflect its growth potential - it reflects the tax and cost cutting value to an acquirer It's not good for employees or the industry as a whole, but large shareholders would IMO be daft not to accept the prices offered | the_doctor | |
20/6/2014 11:00 | the doctor - not grumpy but just regret it hit 4310 before retreating and I only got 4227.33 average ! I use CFds and bought at 3790 a few days ago and not had the big rise you have had if holding the stock . But what a great stock for trading profits of late . Good luck with your holding and I look for re-emtry soon. | arja | |
20/6/2014 09:35 | Are you out of your mind? These tax vehicle takeovers would lead to one thing only - massive value destruction for shareholders. Pfizer is a company in serious decline, an asset stripper that needs to feed itself to stay alive. Both AZN and particularly SHP are high growth companies with excellent and highly enviable prospects | acta_topup | |
20/6/2014 09:27 | arja - how can you be grumpy To get anything more than a 10% rise for a large company is already fantastic particularly since this has already risen significantly over the last year Shire would be daft to reject, but then AZ did with Pfizer (so far) neither company will grow to these levels independently IMO | the_doctor | |
20/6/2014 08:38 | I sold on opening to my regret as it went higher but now retreating ! I am a little surprised it has done so well as t/o rejected but market must think it is not dead in the water . Should be good to trade today if timing right ! | arja | |
20/6/2014 08:34 | crazy prices - again, more about tax and cost cutting than anything else | the_doctor | |
20/6/2014 07:15 | Well done any holders !! | alchemy30 | |
20/6/2014 07:09 | shire refused 46 quid a share! | dafad | |
20/6/2014 07:09 | shire refused 46 quid a share! | dafad |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions